Comparison of Antiemetic Effectiveness of Palonosetron Versus Ondansetron in Patients on Cancer Chemotherapy: A Prospective Observational Study in South Indians

Comparison of Antiemetic Effectiveness of Palonosetron Versus Ondansetron in Patients on Cancer Chemotherapy: A Prospective Observational Study in South Indians

Introduction: Chemotherapy Induced Nausea and Vomiting (CINV) is the most distressing side effect of cancer chemotherapy. It can seriously produce an impact on patient's quality of life. Prevention of CINV is far more effective than treatment of an established CINV. If the patient receives...

Full description

Bibliographic Details
Main Authors:	Abdul Aslam Parathoduvil, Asha Sisupalan, Padanayil Lekshmikutty Rema
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2017-05-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	antiemetic prophylaxis chemotherapy induced nausea and vomiting 5ht3 receptor antagonists
Online Access:	https://jcdr.net/articles/PDF/9818/25129_CE[Ra]_F(Sh)_PF1(SY_SS)_PFA(P_SY).pdf

Similar Items

An Evidence Practice Gap in Antiemetic Prescription with Chemotherapy
by: Chepsy C-Philip, et al.
Published: (2015-10-01)

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics
by: May MB, et al.
Published: (2016-05-01)

Evaluating the antiemetic administration consistency to prevent chemotherapy-induced nausea and vomiting with the standard guidelines: a prospective observational study
by: Vazin A, et al.
Published: (2017-09-01)

An overview of the latest ASCO recommendations about antiemetic prophylaxis for treatment-related nausea and vomiting
by: Mehmet Akif Öztürk
Published: (2017-12-01)

Antiemetic Prophylaxis with Fosaprepitant and 5-HT3-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
by: Cabanillas Stanchi KM, et al.
Published: (2020-09-01)

Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and Cyclophosphamide
by: Suehiro M, et al.
Published: (2021-02-01)

Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies
by: Cabanillas Stanchi KM, et al.
Published: (2019-09-01)

Antiemetic efficacy and safety of a combination of palonosetron, aprepitant, and dexamethasone in patients with testicular germ cell tumor receiving 5-day cisplatin-based combination chemotherapy
by: Hamada, Shota
Published: (2014)

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab
by: Affronti ML, et al.
Published: (2016-12-01)

Role of ganaton in antiemetic therapy. New treatment capacities
by: A. V. Snegovoy, et al.
Published: (2014-08-01)

Recent advances in pharmacotherapy of chemotherapy-induced nausea and vomiting
by: Prasan R Bhandari
Published: (2012-01-01)

Sub-hypnotic dose of propofol as antiemetic prophylaxis attenuates intrathecal morphine-induced postoperative nausea and vomiting, and pruritus in parturient undergoing cesarean section — a randomized control trial
by: Sylvanus Kampo, et al.
Published: (2019-09-01)

Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (house musk shrew)
by: John A Rudd, et al.
Published: (2016-08-01)

Palonosetron has superior prophylactic antiemetic efficacy compared with ondansetron or ramosetron in high-risk patients undergoing laparoscopic surgery: a prospective, randomized, double-blinded study
by: Sung-Hoon Kim, et al.
Published: (2013-06-01)

A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment
by: Janet Hardy, et al.
Published: (2018-05-01)

5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study
by: Reiko Matsui, et al.
Published: (2020-10-01)

Efficacy of Olanzapine for High and Moderate Emetogenic Chemotherapy in Children
by: So Rae Lee, et al.
Published: (2020-09-01)

The Impact of Different Antiemetics on the Nausea in Early Postoperative Period After Laparoscopic Holecystectomy
by: Marijanovic Goran, et al.
Published: (2021-06-01)

Palonosetron versus ondansetron for prevention of nausea and vomiting after total abdominal hysterectomy under spinal anesthesia with intrathecal morphine: a double-blind, randomized controlled trial
by: Guilherme Oliveira Campos, et al.
Published: (2019-08-01)

An Update in Our Understanding of the Relationships Between Gene Polymorphisms and Chemotherapy-Induced Nausea and Vomiting
by: Jin Y, et al.
Published: (2021-09-01)

Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)
by: Hisanori Shimizu, et al.
Published: (2018-12-01)

Avoiding emetogenic anesthetics and using prophylactic antiemetics for patients with high risk of postoperative nausea and vomiting
by: Jia-Fang Syu, et al.
Published: (2021-05-01)

A comparison of the efficacy and cost of intravenous and oral formulations of ondansetron against chemotherapy-induced nausea
by: Mbitsi Ibouily, Gretta Cornelia
Published: (2013)

Caffeine for the prevention of postoperative nausea and vomiting
by: Richard A Steinbrook, et al.
Published: (2013-01-01)

Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients: A Multicenter Prospective Observational Study
by: Xinjuan Huang, et al.
Published: (2021-01-01)

Palonosetron in the prevention of chemotherapy-induced nausea and vomiting in Italy: pharmacoeconomic and clinical aspects
by: Lorenzo Pradelli, et al.
Published: (2007-06-01)

Differential pharmacology and clinical utility of rolapitant in chemotherapy-induced nausea and vomiting
by: Rapoport BL
Published: (2017-02-01)

Ondansetrona oral na prevenção de náuseas e vômitos pós-operatórios The effect of oral ondansetron in the prevention of postoperative náusea and vomiting
by: Elaine Milani Lewaschiw, et al.
Published: (2005-02-01)

Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis
by: Toshinobu Hayashi, et al.
Published: (2021-01-01)

Analysis of Dietary Intake during Consecutive-Day Chemotherapy for Bone and Soft-Tissue Sarcomas
by: Yuta Hori, et al.
Published: (2018-01-01)

Construction and effectiveness of vomit-free ward
by: Yao Zhi-Qi, et al.
Published: (2019-11-01)

Estudio farmacoeconómico de esquemas de tratamiento antiemético en quimioterapia moderada y altamente emetógena Pharmacoeconomic study of antiemetic treatment in moderate and highly emethogenic chemotherapy
by: Noyde Batista Albuerne, et al.
Published: (2010-03-01)

Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting
by: Mayako Uchida, et al.
Published: (2018-01-01)

Comparison of ramosetron with ondansetron for the prevention of post-operative nausea and vomiting in high-risk patients
by: Sandip Agarkar, et al.
Published: (2015-01-01)

Assessment of the Adherence Rate of Acute Chemotherapy Induced Nausea and Vomiting Prophylaxis Regimens by Medical Team to NCCN Clinical Recommendations: Cross-Section Observation
by: Mohammad Mohammadzadeh, et al.
Published: (2021-04-01)

Cost-effectiveness and efficacy of combined dexamethasone–metoclopramide versus ondansetron in the prevention of postoperative nausea and vomiting in women undergoing myomectomy under spinal anesthesia
by: T A Ogbo, et al.
Published: (2019-01-01)

Prevention of Nausea and Vomiting in Oncology
by: AV Snegovoi, et al.
Published: (2016-01-01)

Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
by: Zhao Y, et al.
Published: (2021-01-01)

Management of chemotherapy induced emesis
by: Roila Fausto
Published: (2004-01-01)

Management of chemotherapy induced emesis
by: Roila Fausto
Published: (2004-01-01)